Abstract

We will present our efforts to build a next generation clinical frequency-domain diffuse optical imaging system which will provide ultra-fast and wearable monitoring of the in vivo tumor state during dynamic testing, including chemotherapy infusions.

© 2017 OSA

PDF Article